Metabolic Effects of Duodenal Jejunal Bypass Liner for Type 2 Diabetes Mellitus

CompletedOBSERVATIONAL
Enrollment

19

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Type 2 Diabetes MellitusObesity
Interventions
DEVICE

DJBL (Duodenal jejunal bypass liner, EndoBarrier)

Implantation of EndoBarrier after medical and patient's decision, Duration of treatment 12 months in maximum, follow up for 4 weeks after Explantation, follow up during treatment by physical examination, ECG control, sampling and analysis of blood parameters, mixed meal tolerance tests only for diagnostic purposes to assess gut hormonal changes and metabolic parameters

Trial Locations (1)

32545

Herz- und Diabeteszentrum, Bad Oeynhausen

All Listed Sponsors
lead

Ruhr University of Bochum

OTHER

NCT02800668 - Metabolic Effects of Duodenal Jejunal Bypass Liner for Type 2 Diabetes Mellitus | Biotech Hunter | Biotech Hunter